FI3302512T3 - Koostumuksia ja menetelmiä urheilusuorituksen parantamiseksi - Google Patents

Koostumuksia ja menetelmiä urheilusuorituksen parantamiseksi Download PDF

Info

Publication number
FI3302512T3
FI3302512T3 FIEP16800834.0T FI16800834T FI3302512T3 FI 3302512 T3 FI3302512 T3 FI 3302512T3 FI 16800834 T FI16800834 T FI 16800834T FI 3302512 T3 FI3302512 T3 FI 3302512T3
Authority
FI
Finland
Prior art keywords
exercise
use according
increase
acutely
betalain
Prior art date
Application number
FIEP16800834.0T
Other languages
English (en)
Finnish (fi)
Inventor
Zbigniew Pietrzkowski
Original Assignee
Vdf Futureceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vdf Futureceuticals Inc filed Critical Vdf Futureceuticals Inc
Application granted granted Critical
Publication of FI3302512T3 publication Critical patent/FI3302512T3/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
FIEP16800834.0T 2015-05-27 2016-05-27 Koostumuksia ja menetelmiä urheilusuorituksen parantamiseksi FI3302512T3 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562167229P 2015-05-27 2015-05-27
PCT/US2016/034802 WO2016191736A1 (en) 2015-05-27 2016-05-27 Compositions and methods for increasing athletic performance

Publications (1)

Publication Number Publication Date
FI3302512T3 true FI3302512T3 (fi) 2023-10-04

Family

ID=57393796

Family Applications (1)

Application Number Title Priority Date Filing Date
FIEP16800834.0T FI3302512T3 (fi) 2015-05-27 2016-05-27 Koostumuksia ja menetelmiä urheilusuorituksen parantamiseksi

Country Status (9)

Country Link
US (3) US11446284B2 (https=)
EP (2) EP4233877A3 (https=)
JP (1) JP6833726B2 (https=)
DK (1) DK3302512T3 (https=)
ES (1) ES2959184T3 (https=)
FI (1) FI3302512T3 (https=)
PL (1) PL3302512T3 (https=)
PT (1) PT3302512T (https=)
WO (1) WO2016191736A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7095868B2 (ja) * 2018-07-30 2022-07-05 国立大学法人金沢大学 神経障害性疼痛の医薬組成物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4027042A (en) 1974-10-15 1977-05-31 Wisconsin Alumni Research Foundation Color extract from beets and method for the preparation of same
GB1559275A (en) 1975-10-07 1980-01-16 Lafon Labor Process for the preparation of a stable beta vulgaris extrct
US4238518A (en) 1978-04-28 1980-12-09 Laboratoire L. Lafon Process for the preparation of a stable Beta vulgaris extract
US4409254A (en) 1980-09-29 1983-10-11 General Foods Corporation Process for concentrating and isolating a beet colorant
IL119872A (en) 1996-12-19 2000-01-31 Israel State Pharmaceutical compositions containing antioxidant betalains and a method for their preparation
US20030036565A1 (en) 2001-06-22 2003-02-20 Wisconsin Alumni Research Foundation Cancer chemopreventive agents
US8198512B2 (en) * 2005-02-28 2012-06-12 Wisconsin Alumni Research Foundation High pigment golden beets
WO2008094705A1 (en) * 2007-01-31 2008-08-07 Vdf Futureceuticals, Inc. Solid betalain compositions and methods
DK2124638T3 (en) * 2007-02-26 2017-03-20 Heartbeet Ltd COMPOSITION INCREASING PERFORMANCE AND USING IT
WO2010014839A1 (en) 2008-07-30 2010-02-04 Vdf Futureceuticals, Inc. Betalain compositions and uses thereof
WO2012016018A1 (en) * 2010-07-28 2012-02-02 Vdf Futureceuticals, Inc. Compositions and methods for improvement of oxygen metabolism and cytokine regulation
EP2420243A1 (en) * 2010-08-18 2012-02-22 Inovativo Biomedicinas Tehnologiju Instituts, SIA Compositions obtainable from bred beetroot juice to promote iron absorption and blood forming
TW201318566A (zh) * 2011-11-01 2013-05-16 呂健民 膳食補充劑組合物及其用於調控血糖之方法
US20140087011A1 (en) * 2012-05-16 2014-03-27 Louise M. Smith RyWhe / The Drink of Life
DE102014007762A1 (de) * 2013-05-31 2014-12-04 Gabriele Pütz Kohlehydrat-Konzentrat, Verfahren zu seiner Herstellung und wässriges Getränkekonzentrat
US20160303176A1 (en) * 2015-04-15 2016-10-20 Erroll J. Bailey Nutritional supplement
CN105285634B (zh) 2015-11-11 2017-12-01 浙江工商大学 一种运动训练提效型天然功能饮剂组合物及其应用

Also Published As

Publication number Publication date
US12551473B2 (en) 2026-02-17
EP3302512A4 (en) 2019-02-13
JP2018515590A (ja) 2018-06-14
EP4233877A2 (en) 2023-08-30
JP6833726B2 (ja) 2021-02-24
EP3302512A1 (en) 2018-04-11
WO2016191736A1 (en) 2016-12-01
ES2959184T3 (es) 2024-02-21
US20240226077A1 (en) 2024-07-11
US11446284B2 (en) 2022-09-20
PT3302512T (pt) 2023-10-13
DK3302512T3 (da) 2023-10-09
EP4233877A3 (en) 2023-10-25
PL3302512T3 (pl) 2023-12-18
US20220387409A1 (en) 2022-12-08
US20180296544A1 (en) 2018-10-18
EP3302512B1 (en) 2023-07-05
US11944610B2 (en) 2024-04-02

Similar Documents

Publication Publication Date Title
AU2009217031B2 (en) Use of compounds binding to the sigma receptor ligands for the treatment of neuropathic pain developing as a consequence of chemotherapy
HRP20191288T1 (hr) Pripravak koji sadrži smjesu ekstrakata iz biljaka ili smjesu molekula koje se nalaze u tim biljkama, te upotreba namijenjena djelovanju na metabolizam glucida i/ili lipida
HRP20221106T1 (hr) Postupci liječenja abnormalnih nevoljnih poremećaja pokreta
FI4349369T3 (fi) Lääkkeen biologisen hyötyosuuden lisääminen naltreksonihoidossa
AR069541A1 (es) Trans- clomifeno para el sindrome metabolico
Aalizadeh et al. The effect of short-term plyometric training program on sprint, strength, power and agility performance in non-athletic men
RU2017122148A (ru) Способы и композиции для сохранения безжировой массы тела и стимулирования потери жира во время потери массы
MX384303B (es) Composiciones y métodos para metabolismo muscular mejorado.
Zhang et al. The effects of exercise and restriction of sugar-sweetened beverages on muscle function and autophagy regulation in high-fat high-sucrose-fed obesity mice
FI3302512T3 (fi) Koostumuksia ja menetelmiä urheilusuorituksen parantamiseksi
Zhang et al. The effects on type 2 diabetes mellitus mouse femoral bone achieved by anti-osteoporosis exercise interventions
Takayama et al. Pacing strategy in a 24-hour ultramarathon race
BR112012013207A2 (pt) método para produzir uma bebida/produto alimentício tendo um aroma e/ou sabor aprimorado, composição para conferir aroma e/ou sabor, produto alimentício, e, métodos para aprimorar um aroma e/ou um sabor de um produto alimentício e para produzir um produto alimentício tendo um aroma e/ou sabor aprimorado.
JP2017001966A5 (https=)
MX2018007065A (es) El uso de una composicion para reducir el nivel de colesterol en un mamifero, un metodo para su preparacion, una composicion y un metodo para preparar un aditivo alimenticio que comprende tal composicion.
JP2014012659A5 (https=)
BR112014012591A8 (pt) composição colorante pronta para uso contendo um componente a; e produto para uso separado em função do tempo
JPWO2020130146A5 (https=)
RU2016110879A (ru) Регулятор уровня экспрессии часовых генов
Eui-sik et al. Effects of Qigong Training on Body Composition, Fitness and Bone Mineral Density in the Elderly
Li et al. Efficacy and safety of Shen-Qi Paste, a Traditional Chinese Medicine, in dialysis patients with sarcopenia: A randomized, double-blind, placebo-controlled trial
RU2017142726A (ru) Офтальмическая композиция, содержащая липоевую кислоту и мукомиметический полимер
JP2018515590A5 (https=)
Xu et al. Effect Of 12 Weeks Aerobic Exercise With Different Intensity On Cardiorespiratory Fitness In Rats: 3283 Board# 44 May 30, 9: 30 AM-11: 00 AM
Paes et al. Effects Of Isocaloric Aerobic Training With Different Intensities Upon Fitness, Adiposity And Microcirculation In Rats: 3282 Board# 43 May 30, 9: 30 AM-11: 00 AM